Canada Clinical Nutrition Market Insights Forecasts to 2033

• The Canada Clinical Nutrition Market Size was valued at USD 640.5 Million in 2023.
• The Market is growing at a CAGR of 5.27% from 2023 to 2033
• The Canada Clinical Nutrition Market Size is expected to reach USD 1070.5 Million by 2033

The Canada Clinical Nutrition Market is anticipated to exceed USD 1070.5 Million by 2033, growing at a CAGR of 5.27% from 2023 to 2033. The increasing prevalence of malnutrition, obesity, and chronic diseases, growing awareness about nutrition, and acquisitions by market players are driving the growth of the clinical nutrition market in Canada.     

Market Overview

Clinical nutrition refers to the prevention, diagnosis, and management of nutritional changes. It is the practice of analyzing a patient’s nutritional status, which involves the evaluation of the patient’s medical history, laboratory test results, and dietary intake. These nutrition aids to promote health and prevent disease in individuals, especially in a healthcare context. The increasing use of bioactive substances, customized nutrition solutions, and inventive formulations are the key trends driving the market. There is an increasing investment in research and development for manufacturing products that meet basic nutritional needs and health benefits. Furthermore, there is a growing emphasis on individualized nutrition and the incorporation of digital health technology like wearables, smartphone apps, and telemedicine platforms.

Report Coverage

This research report categorizes the market for the Canada clinical nutrition market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Canada clinical nutrition market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Canada clinical nutrition market.

Driving Factors

A recent Statistics Canada research found that one-third of Canadians 65 years of age and older are at risk of malnutrition. The increased prevalence of malnutrition among the geriatric population in Canada is responsible for driving the market. The increasing prevalence of obesity and chronic diseases is driving the demand for nutrition interventions for health improvement, thereby driving the market demand. There is an increasing awareness about nutrition in the country, which is contributing to propel the market. For instance, the Canadian Malnutrition Task Force (CMTF), a standing committee of the Canadian Nutrition Society (CNS) presented an educational and promotional campaign, Canadian Malnutrition Awareness Week (CMAW) that would focus on increasing awareness of malnutrition across adult and pediatric acute care, primary & community care & long term care. 

Restraining Factors

The stringent regulatory framework for new product approvals is challenging the Canada clinical nutrition market.

Market Segmentation

The Canada Clinical Nutrition Market share is classified into product type, application, and sales channel.

• The enteral nutrition dominated the market with a significant market share during the forecast period.

The Canada clinical nutrition market is segmented by product type into enteral nutrition and parenteral nutrition. Among these, the enteral nutrition dominated the market with a significant market share during the forecast period. Enteral nutrition involves the delivery of nutrition to the body via the digestive tract including the use of liquid supplements and tube feeding. According to Health Canada, in 2021, over 650,000 Canadians received enteral nutrition. These factors are driving the market growth in the enteral nutrition segment.

• The cancer segment dominated the Canada clinical nutrition market during the forecast period.       

Based on the application, the Canada clinical nutrition market is divided into diabetes, cancer, critical care, neurological disorder, metabolic syndrome, gastrointestinal diseases, and others. Among these, the cancer segment dominated the Canada clinical nutrition market during the forecast period. Cancer and cancer therapy cause malnutrition due to a lack of key nutrients. As per estimates, 2 in 5 Canadians are expected to be diagnosed with cancer in their lifetime and 1 in 4 would die from cancer. The increasing cases of cancer in the country drive the market demand for clinical nutrition.

• The institutional sales channels segment is dominating the Canada clinical nutrition market with the largest market share in 2023.

The Canada clinical nutrition market is segmented by sales channel into retail sales channels, online sales channels, and institutional sales channels. Among these, the institutional sales channels segment is dominating the Canada clinical nutrition market with the largest market share in 2023. Institutional sales include purchasing of clinical nutrition products by hospitals, long-term care centers, hospices, and disability facilities. The growing prevalence of chronic diseases in the country with the increasing number of private and public institutions is driving the market.  

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Canada clinical nutrition market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Nutrition
• Nutrica North America
• Nestle
• Vicore Pharma Holding
• Baxter International Inc.
• Bayer AG
• Danone
• Cambrooke Therapeutics
• Otsuka Holdings Co., Ltd.
• Mead Johnson & Company, LLC
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In May 2020, Nestlé is set to acquire privately-held Canadian vitamin company Atrium Innovations for $2.3bn. the move would see Nestlé further grow its consumer healthcare business and become a global leader in nutritional health products, as well as enhance its high-growth food and beverage categories.

Market Segment

This study forecasts revenue at Canada, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Canada Clinical Nutrition Market based on the below-mentioned segments

Canada Clinical Nutrition Market, By Product Type

• Enteral Nutrition
• Parenteral Nutrition

Canada Clinical Nutrition Market, By Application

• Diabetes
• Cancer
• Critical Care
• Neurological Disorder
• Metabolic Syndrome
• Gastrointestinal Diseases
• Others

Canada Clinical Nutrition Market, By Sales Channel

• Retail Sales Channels
• Online Sales Channels
• Institutional Sales Channels